期刊文献+

阿托伐他汀预防新发房颤的临床研究 被引量:3

下载PDF
导出
摘要 目的:观察阿托伐他汀对房颤的影响。方法:将未患房早、室上速、房颤的患者364例随机分为两组。阿托伐汀组予服用阿托他汀片,对照组未服阿托他汀片。于服药前1周及服药后第18个月后1周内行超声心动图(Holter)检查有无房颤发生。试验中阿托伐他汀组由于产生不良反应及其他原因,有部分患者未能坚持服用阿托他汀片,故阿托伐他汀组又分为长期服药组和间断服药组。结果:无论长期服用阿托伐他汀片或间断服用阿托他汀片,房颤发生率均较对照组低,尤其长期服用阿托伐汀组(7.59%)较对照组(15.69%)房颤发生率明显降低(P<0.05)。间断服用阿托伐他汀组(10.26%)与长期服用阿托他汀组比较房颤发生率无统计学意义(P>0.05)。结论:长期服用阿托伐汀片有明显的预防房颤发生的作用。
出处 《中国社区医师(医学专业)》 2010年第28期33-33,共1页
  • 相关文献

参考文献3

  • 1Wolf PA, Abboh RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke : the Framingham Study [ J ]. Stroke, 1991,2 (8) :983 -988.
  • 2Benjamin E J, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death : the Framingham heart [J]. Circulation, 1998,98 (10) :946 - 952.
  • 3Engelmann M, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation[ J]. Eur Heart J ,2005,26:2083 - 2092.

同被引文献21

  • 1戚文航.血管紧张素受体拮抗剂与心房颤动[J].中华心血管病杂志,2004,32(11):1042-1043. 被引量:93
  • 2杜昕,刘晓惠,马长生.心房颤动的药物治疗[J].中华心律失常学杂志,2005,9(2):129-132. 被引量:33
  • 3Young XY, Jabbour S, Goldberg R, et al. Usefulness of statin drugsinprotecting against atrial fibrillation in patients with coronary arterydisease[J]. Am J Cardiol, 2003, 92(12) : 1379-1384.
  • 4Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide ep- idemiology of atrial fibrillation: a global burden of disease 2010 study[-J]. Circulation, 2014,129 (8) : 837-847.
  • 5Mayyas F, Alzoubi KH, Van Wagoner DR. Impact of aldo- sterone antagonists on the substrate for atrial fibrillation:aldosterone promotes oxidative stress and atrial structural/ electrical remodeling[J]. International journal of cardiology, 2013,168 (6) :5135-5142.
  • 6Gensini GF,Gori AM,Dilaghi B, et al. Effect of atorvastatin on circulating hsCRP concentrations; a sub-study of the a- chieve cholesterol targets fast with atorvastatin stratified ti- tration (ACTFAST) study[J]. International journal of car- diology,2014,142 (3) :257-264.
  • 7Negi S, Shukrullah I, Veledar E, et al. Statin therapy for the prevention of atrial fibrillation trial (STOP AF trial). Jour- nal of cardiovascular electrophysiology [J ]. 2011,22 (4) : 414-419.
  • 8Lappegard KT, Pop- Purceleanu M, van Heerde W, et al. Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy[J]. Journal of neuroinflammation , 2013,10 : 78.
  • 9Anderson JL, Halperin JL, Albert NM, et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/ AHA/ESC and 2011 ACCF/AHA/HRS recommenda- tions): a report of the American College of Cardiology/A- merican Heart Association Task Force on Practice Guide- lines[J]. Journal of the American College of Cardiology, 2013,61 (18) :193-1944.
  • 10甘文云,唐其柱,王蕾,田青,周恒.高敏C反应蛋白在房颤中的意义及其与心功能的关系[J].实用医学杂志,2009,25(4):586-587. 被引量:10

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部